Licensing allows the holder of a patent or other IP rights to grant permission to another party to use their invention or work. This can facilitate collaborations between academic institutions, research organizations, and pharmaceutical companies, enabling the development and commercialization of new cancer treatments. Licensing agreements can be structured to balance the interests of both parties, promoting innovation and broader dissemination of research findings.
